RxDoctor Payments Data

Richard Berliner, DPM

Primary Podiatric Medicine · Mount Kisco, NYNPI 1740218171

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $404 and has fallen 62.0% since, to $153 in 2025.

$1,498in general payments, 2019–2025

Across 44 payments — averaging $34.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$343
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$223
  • Organogenesis Inc.$211
  • Alfasigma USA, Inc.$209
  • Next Science LLC$145
  • Gotham Surgical Solutions & Devices, Inc.$120
  • plus $246 from 5 others

What the payments were for

  • Food & beverage$1,498100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,498 in reported general payments places this provider in the 70th percentile of 85 primary podiatric medicine providers in New York.

See all primary podiatric medicine providers in New York

Medicare billing

Part B allowed, 2024
$89,874
Medicare patients
376
Services billed
1,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine27$962
Ammonium Lactate36$572
Terbinafine Hcl11$66

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Mount Kisco

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →